PRINCIPAL FINANCIAL GROUP INC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1126328
DES MOINES, IA
Position in LGND
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$30,967,653
+$11,857,954 QoQ
Shares Held
97,971
+2.4% QoQ
Ownership
0.491%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#48
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,857,842,341 across 105 Biotechnology names. LGND ranks #20 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,967,653 | 97,971 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $19,109,699 | 95,716 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $17,740,437 | 93,830 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $16,757,797 | 94,602 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $11,573,987 | 101,812 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $10,816,171 | 102,874 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $10,671,067 | 99,590 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $9,329,188 | 93,208 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $7,479,675 | 88,769 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $6,734,263 | 92,124 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $6,628,489 | 92,810 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $5,637,153 | 94,078 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $7,070,125 | 98,060 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $7,478,844 | 101,670 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $6,918,408 | 103,569 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $8,811,114 | 102,324 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $10,171,161 | 114,001 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $13,770,581 | 122,416 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $20,227,919 | 130,959 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $23,086,845 | 165,711 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $14,404,398 | 109,798 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $15,398,816 | 101,009 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $8,804,603 | 88,533 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $9,443,160 | 99,068 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $8,832,120 | 78,964 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $3,763,620 | 51,755 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||